EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Allergens And Allergen Immunotherapy 3rd Ed Rev And Expanded Samuel C Bukantz

Name: Allergens And Allergen Immunotherapy 3rd Ed Rev And Expanded Samuel C Bukantz
SKU: BELL-1397526
Price: 31.00 USD
Availability: InStock
Rating: 4.25 (68 reviews)

SKU: BELL-1397526

$ 31.00 ~~$ 45.00~~ (-31%)

4.3

68 reviews

Allergens And Allergen Immunotherapy 3rd Ed Rev And Expanded Samuel C Bukantz instant download after payment.

Publisher: Marcel Dekker

File Extension: PDF

File size: 7.63 MB

Pages: 831

Author: Samuel C. Bukantz, Richard F. Lockey, Jean Bousquet

ISBN: 9780824752514, 9780824756505, 0824756509, 0824752511

Language: English

Year: 2004

Edition: 3rd ed., rev. and expanded

Product desciption

Allergens And Allergen Immunotherapy 3rd Ed Rev And Expanded Samuel C Bukantz by Samuel C. Bukantz, Richard F. Lockey, Jean Bousquet 9780824752514, 9780824756505, 0824756509, 0824752511 instant download after payment.

Enlarged to describe more than a decade of advances in the immunotherapy of allergic diseases and asthma, this Third Edition contains the most recent studies on the mechanisms, manufacture, and standardization of various allergen groups and their utilization in the treatment of allergic diseasesвЂ”containing 8 new chapters detailing various pharmacoeconomic, regulatory, manufacturing, administration, and safety issues concerning new and emerging immunotherapy techniques.